There is one clinical trial.

Clinical Trials

1 Open-label, Randomised, Single Oral Dose, Two-period, Cross-over Trial to Assess to Bioequivalence of Favira 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions

A single dose of Reference product containing 200 mg favipiravir and a single dose of Test product containing 200 mg favipiravir or vice versa; administered with 240 mL of water at room temperature, in each period under fasting conditions with current pandemic precautions.

NCT04400682 Bioequivalence Drug: FAVIRA 200 MG Film Tablet Drug: AVIGAN 200 MG Film Tablets

No related HPO nodes (Using clinical trials)